gammanorm 165 mg/ml inj. opl. s.c./i.m. flac.
octapharma benelux sa-nv - humane normale immunoglobulinen 165 mg/ml - oplossing voor injectie - 165 mg/ml - humane normale immunoglobulinen 165 mg/ml - immunoglobulins, normal human, for extravascular adm.
gammanorm 165 mg/ml inj. opl. s.c./i.m. flac.
octapharma benelux sa-nv - humane normale immunoglobulinen 165 mg/ml - oplossing voor injectie - 165 mg/ml - humane normale immunoglobulinen 165 mg/ml - immunoglobulins, normal human, for extravascular adm.
gammanorm 165 mg/ml inj. opl. s.c./i.m. flac.
octapharma benelux sa-nv - humane normale immunoglobulinen 165 mg/ml - oplossing voor injectie - 165 mg/ml - humane normale immunoglobulinen 165 mg/ml - immunoglobulins, normal human, for extravascular adm.
eprivalan 5 mg/ml pour-on oplossing voor vlees- en melkvee
boehringer ingelheim animal health netherlands b.v. - eprinomectine - pour-on oplossing - eprinomectin
gastrogard 370 mg/g pasta voor oraal gebruik voor paarden
boehringer ingelheim animal health netherlands bv - omeprazol - pasta voor oraal gebruik - omeprazol 370, - omeprazole - paarden
prontax 5 mg/ml pour-on oplossing voor runderen
zoetis b.v. - doramectin - pour-on oplossing - doramectin 5 mg/ml, - doramectin - runderen
eprivalan 5 mg/ml pour-on oplossing
boehringer ingelheim animal health belgium - eprinomectine - pour-on oplossing - 5 mg/ml - eprinomectine 5 mg/ml - eprinomectin - rund
gastrogard 370 mg/g or. pasta voorgev. spuit
boehringer ingelheim animal health belgium - omeprazol 370 mg/g - pasta voor oraal gebruik - 370 mg/g - omeprazol 370 mg/g - omeprazole - paard
omeproshield 370 mg/g or. pasta voorgev. spuit
boehringer ingelheim animal health france - omeprazol 370 mg/g - pasta voor oraal gebruik - 370 mg/g - omeprazol 370 mg/g - omeprazole - paard
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccins - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.